Blockade effect of mu and kappa opioid antagonists on the anti-nociception induced by intra-periaqueductal grey injection of oxytocin in rats

Brain Res. 2002 Feb 15;927(2):204-7. doi: 10.1016/s0006-8993(01)03346-7.

Abstract

Intra-periaqueductal grey (PAG) injection of 1 nmol of oxytocin induced significant increases in hindpaw withdrawal latency (HWL) to thermal and mechanical stimulation in rats. The anti-nociceptive effect of oxytocin was attenuated significantly by subsequent intra-PAG injection of the mu opioid antagonist beta-funaltrexamine (beta-FNA) and the kappa opioid antagonist nor-binaltorphimine (nor-BNI), but not by the delta antagonist naltrindole. The results demonstrated that mu and kappa opioid receptors, not delta receptors, were involved in the oxytocin-induced anti-nociception in PAG of rats.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analgesics / administration & dosage*
  • Animals
  • Injections, Intraventricular
  • Male
  • Narcotic Antagonists / pharmacology
  • Oxytocin / administration & dosage*
  • Oxytocin / physiology
  • Pain Measurement / drug effects
  • Periaqueductal Gray / drug effects*
  • Periaqueductal Gray / physiology
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Opioid, kappa / antagonists & inhibitors*
  • Receptors, Opioid, kappa / physiology
  • Receptors, Opioid, mu / antagonists & inhibitors*
  • Receptors, Opioid, mu / physiology

Substances

  • Analgesics
  • Narcotic Antagonists
  • Receptors, Opioid, kappa
  • Receptors, Opioid, mu
  • Oxytocin